Detalles de la búsqueda
1.
Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 "Lynch-like" mismatch repair gene mutation.
Gynecol Oncol;
177: 132-141, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37683549
2.
HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosis.
Gynecol Oncol;
172: 98-105, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37003074
3.
HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression.
J Immunol;
206(10): 2478-2488, 2021 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903172
4.
Opposing Roles of SPOP Mutations in Human Prostate and Endometrial Cancers.
JCO Precis Oncol;
7: e2300088, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37677121
5.
Multi-omic characterization reveals a distinct molecular landscape in young-onset pancreatic cancer.
medRxiv;
2023 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37034762
6.
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases.
NPJ Precis Oncol;
7(1): 120, 2023 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37964004
7.
Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer.
JCO Precis Oncol;
7: e2300152, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37944072
8.
Prognostic immunologic signatures in epithelial ovarian cancer.
Oncogene;
41(10): 1389-1396, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35031772
9.
A bioinformatic analysis of WFDC2 (HE4) expression in high grade serous ovarian cancer reveals tumor-specific changes in metabolic and extracellular matrix gene expression.
Med Oncol;
39(5): 71, 2022 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35568777
10.
Intratumoral expression analysis reveals that OX40 and TIM-3 are prominently expressed and have variable associations with clinical outcomes in high grade serous ovarian cancer.
Oncol Lett;
23(6): 188, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35527785
11.
Adaptive transcriptomic and immune infiltrate responses in the tumor immune microenvironment following neoadjuvant chemotherapy in high grade serous ovarian cancer reveal novel prognostic associations and activation of pro-tumorigenic pathways.
Front Immunol;
13: 965331, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36131935
12.
Immune Modeling Analysis Reveals Immunologic Signatures Associated With Improved Outcomes in High Grade Serous Ovarian Cancer.
Front Oncol;
11: 622182, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33747935
13.
The Perfect Combination: Enhancing Patient Response to PD-1-Based Therapies in Epithelial Ovarian Cancer.
Cancers (Basel);
12(8)2020 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32756436
14.
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes.
Sci Rep;
10(1): 8558, 2020 05 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32444701
15.
Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins.
Oncotarget;
10(31): 2959-2972, 2019 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31105878
16.
Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genes.
Oncotarget;
10(36): 3315-3327, 2019 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31164954
17.
Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6.
Front Pharmacol;
10: 216, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30941033
18.
Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer.
Front Oncol;
8: 124, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29740539
19.
Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix.
Front Oncol;
7: 332, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29404274
20.
Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers.
Sci Rep;
5: 15911, 2015 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-26568478